A randomised phase 2 study of Panitumumab Monotherapy and Panitumumab Plus 5 Fluorouracil as first line therapy for RAS and BRAF wild type metastatic colorectal cancer. MONARCC

Segelov, Eva (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Details

Project Description

NHM HREC Ref number: HREC/17/RPAH/365
NMA SSA Ref number: SSA/18/MonH/70
Monash Health Ref: RES-18-0000-078X
SEO Code: 920102 Cancer and Related Disorders

Status	Active
Effective start/end date	7/02/18 → 16/10/23

View all

View less